Hagop Kantarjian

The field of BPDCN is rapidly evolving – Hagop Kantarjian

The field of BPDCN is rapidly evolving.

Our new article by Dr. Pemmaraju highlights the new era of targeting CD123 in combinations & beyond.

https://pubmed.ncbi.nlm.nih.gov/37145496/

The field of BPDCN is rapidly evolving - Hagop Kantarjian

Source: Hagop Kantarjian / Twitter

BPDCN CD123 Hagop Kantarjian Kantarjian Naveen Pemmaraju